User profiles for C. Vogel
Christine VogelNew York University, Center for Genomics and Systems Biology, Dept. of Biology Verified email at nyu.edu Cited by 15040 |
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
C Vogel, EM Marcotte - Nature reviews genetics, 2012 - nature.com
… c | Nonetheless, mRNA levels are an excellent proxy (in general) for the presence of a protein
… Panel c of this figure is adapted, with permission, from Ref. 42 © (2009) Oxford University …
… Panel c of this figure is adapted, with permission, from Ref. 42 © (2009) Oxford University …
Global signatures of protein and mRNA expression levels
… Christine Vogel is a research associate … c-myc Single mutation in the c-myc IRES causes
enhanced initiation of translation via a cap-independent mechanism and promotes excess of c…
enhanced initiation of translation via a cap-independent mechanism and promotes excess of c…
The spectrum of the disease in 98 patients
RC Young, JE Bennett, CL Vogel, PP Carbone… - Medicine, 1970 - journals.lww.com
Invasive fungal diseases are becoming increasingly important in patient populations whose
host defenses have been altered by severe primary disease or immunosuppressive therapy. …
host defenses have been altered by severe primary disease or immunosuppressive therapy. …
The causes of land-use and land-cover change: moving beyond the myths
Common understanding of the causes of land-use and land-cover change is dominated by
simplifications which, in turn, underlie many environment-development policies. This article …
simplifications which, in turn, underlie many environment-development policies. This article …
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer
CL Vogel, MA Cobleigh, D Tripathy… - Journal of clinical …, 2023 - ingentaconnect.com
PURPOSE To evaluate the efficacy and safety of first-line, single-agent trastuzumab in
women with HER2-overexpressing metastatic breast cancer. PATIENTS AND METHODS One …
women with HER2-overexpressing metastatic breast cancer. PATIENTS AND METHODS One …
[PDF][PDF] Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer …
MA Cobleigh, CL Vogel, D Tripathy… - Journal of clinical …, 1999 - researchgate.net
… Therefore, 176 patients (84%) did not have postinfusion temperatures that exceeded 38C. …
Vogel CL: Current status of salvage chemotherapy for refractory advanced breast cancer. …
Vogel CL: Current status of salvage chemotherapy for refractory advanced breast cancer. …
[BOOK][B] Computational methods for inverse problems
CR Vogel - 2002 - SIAM
The field of inverse problems has experienced explosive growth in the last few decades. This
is due in part to the importance of applications, like biomedical and seismic imaging, that …
is due in part to the importance of applications, like biomedical and seismic imaging, that …
[HTML][HTML] Adjuvant docetaxel for node-positive breast cancer
Background We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with
fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for …
fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for …
Iterative methods for total variation denoising
CR Vogel, ME Oman - SIAM Journal on Scientific Computing, 1996 - SIAM
… , this method exhibits rapid linear convergence for a broad range ofthe parameters c and/3. …
Figure 2 shows the qualitative effects of varying the parameters c and/3 on the minimizer of …
Figure 2 shows the qualitative effects of varying the parameters c and/3 on the minimizer of …
The effectiveness of early head start for 3-year-old children and their parents: lessons for policy and programs.
…, PZ Schochet, D Paulsell, C Vogel - Developmental …, 2005 - psycnet.apa.org
… nationally implemented community-based programs to alter child development trajectories
(in contrast to single-site demonstration programs implemented by individual investigators); (c…
(in contrast to single-site demonstration programs implemented by individual investigators); (c…